Looking at Marine-Derived Bioactive Molecules as Upcoming Anti-Diabetic Agents: A Special Emphasis on PTP1B Inhibitors

Autor: Mehdi Sharifi-Rad, Natália Martins, Solomon Habtemariam, Javad Sharifi-Rad, Bahare Salehi, Shahira M. Ezzat, Mahitab H. El Bishbishy
Přispěvatelé: Instituto de Investigação e Inovação em Saúde
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Drug
Enzyme Inhibitors / isolation & purification
type 2 diabetes mellitus
media_common.quotation_subject
Phosphatase
Pharmaceutical Science
Enzyme Inhibitors / chemistry
Review
Biology
Pharmacology
01 natural sciences
Analytical Chemistry
lcsh:QD241-441
03 medical and health sciences
Insulin resistance
lcsh:Organic chemistry
Diabetes mellitus
Drug Discovery
medicine
Hypoglycemic Agents
Animals
Humans
Physical and Theoretical Chemistry
Enzyme Inhibitors
protein-tyrosine phosphatase 1B
Ecosystem
Protein Tyrosine Phosphatase
Non-Receptor Type 1 / metabolism

media_common
Protein Tyrosine Phosphatase
Non-Receptor Type 1

Protein Tyrosine Phosphatase
Non-Receptor Type 1 / antagonists & inhibitors

010405 organic chemistry
Organic Chemistry
marine metabolites
Type 2 Diabetes Mellitus
Enzyme Inhibitors / pharmacology
Marine invertebrates
medicine.disease
Obesity
0104 chemical sciences
Hypoglycemic Agents / pharmacology
Insulin receptor
insulin signaling pathways
030104 developmental biology
Chemistry (miscellaneous)
biology.protein
Molecular Medicine
Zdroj: Molecules, Vol 23, Iss 12, p 3334 (2018)
Molecules
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
ISSN: 1420-3049
Popis: Diabetes mellitus (DM) is a chronic metabolic disease with high morbimortality rates. DM has two types: type 1, which is often associated with a total destruction of pancreatic beta cells, and non-insulin-dependent or type 2 diabetes mellitus (T2DM), more closely associated with obesity and old age. The main causes of T2DM are insulin resistance and/or inadequate insulin secretion. Protein-tyrosine phosphatase 1B (PTP1B) negatively regulates insulin signaling pathways and plays an important role in T2DM, as its overexpression may induce insulin resistance. Thus, since PTP1B may be a therapeutic target for both T2DM and obesity, the search for novel and promising natural inhibitors has gained much attention. Hence, several marine organisms, including macro and microalgae, sponges, marine invertebrates, sea urchins, seaweeds, soft corals, lichens, and sea grasses, have been recently evaluated as potential drug sources. This review provides an overview of the role of PTP1B in T2DM insulin signaling and treatment, and highlights the recent findings of several compounds and extracts derived from marine organisms and their relevance as upcoming PTP1B inhibitors. In this systematic literature review, more than 60 marine-derived metabolites exhibiting PTP1B inhibitory activity are listed. Their chemical classes, structural features, relative PTP1B inhibitory potency (assessed by IC 50 values), and structure–activity relationships (SARs) that could be drawn from the available data are discussed. The upcoming challenge in the field of marine research—metabolomics—is also addressed. N. Martins would like to thank the Portuguese Foundation for Science and Technology (FCT–Portugal) for the Strategic project, reference numbers UID/BIM/04293/2013 and “NORTE2020-Programa Operacional Regional do Norte” (NORTE-01-0145-FEDER-000012).
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje